MDTNEUTRAL

Current Ratio

2.13x

Updated 54h ago

Sector Performance

80th percentile

MDT

2.13x

Sector Median

1.20x

Sector Avg

2.57x

📊

Deep Analysis

MDT’s current ratio of 2.13x means it has $2.13 in short-term assets for every $1 of current liabilities, indicating a comfortable ability to cover upcoming obligations.

This ratio sits well above the sector median of 1.20x, placing the company in the 80th percentile among its peers—stronger liquidity than most. However, because the year-over-year change and quarter-over-quarter change are both listed as N/A, there is no trend data available to assess whether this liquidity position is improving or deteriorating. The combination of a high current ratio with no trend direction implies that while MDT currently faces low short-term risk, investors lack insight into recent shifts in working capital management. This metric alone neither contradicts nor strongly supports the NEUTRAL overall verdict; the adequate liquidity aligns with a neutral stance, but the absence of trend data prevents drawing a more definitive conclusion.

Frequently Asked Questions

What does the Current Ratio tell investors about MDT?

Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.

How is the Current Ratio calculated?

Current Ratio is calculated as: Current Assets / Current Liabilities.

Who are MDT's closest peers by Current Ratio?

The closest peers by Current Ratio include: KEY (0.42x), GEN (0.40x), CHTR (0.40x), USB (0.40x), DRI (0.39x).

The Formula

Current Assets / Current Liabilities

Why It Matters

Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.

Advertisement

Master MDT's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full MDT research report

Free account — no credit card

MDT

2.13x

Sector Median

1.20x

Sector Avg

2.57x

How MDT's Current Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.